New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 3, 2013
10:00 EDTCLDX, ROL, MAN, CTAS, MMLP, RHI, GMT, CQP, MNK, ASGN, ECL, FOXAOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: 21st Century Fox (FOXA) initiated with a Buy at Needham... Cheniere Energy Partners (CQP) initiated with an Outperform at RBC Capital... Cintas (CTAS) initiated with an Outperform at RBC Capital... Ecolab (ECL) initiated with an Outperform at RBC Capital... GATX Corp. (GMT) initiated with an Equal Weight at Stephens... Manpower (MAN) initiated with a Sector Perform at RBC Capital... On Assignment (ASGN) initiated with an Outperform at RBC Capital... Robert Half (RHI) initiated with an Outperform at RBC Capital... Rollins (ROL) initiated with a Sector Perform at RBC Capital... Mallinckrodt (MNK) initiated with a Buy at BofA/Merrill... Martin Midstream Partners (MMLP) initiated with a Neutral at BofA/Merrill... Celldex (CLDX) initiated with a Buy at Guggenheim.
News For FOXA;CQP;CTAS;ECL;GMT;MAN;ASGN;RHI;ROL;MNK;MMLP;CLDX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 29, 2015
17:43 EDTMNKOrexigen in manufacturing pact with Mallinckrodt for naltrexone
Subscribe for More Information
May 28, 2015
09:24 EDTMNKJefferies sees Pharma M&A continuing, lists 22 possible targets
Jefferies analyst David Steinberg believes the M&A wave in the Pharmaceuticals space that began in 2005 can continue as the key drivers remain largely intact. In a note titled "Who is Next? The Feeding Frenzy in Specialty Pharmaceuticals," Steinberg sees deals continuing amid cheap debt, the push for lower corporate taxes and investors rewarding many acquirers for their transactions. He points out there are now around 100 publicly traded Specialty Pharmaceutical companies following the recent life sciences IPO boom. Potential takeover targets, according to Steinberg, include Valeant (VRX), Shire (SHPG), Perrigo (PRGO), Zoetis (ZTS), Mallinckrodt (MNK), Jazz Pharmaceuticals (JAZZ), United Therapeutics (UTHR), Pacira (PCRX), Indivior, Insys Therapeutics (INSY), The Medicines Co. (MDCO), Depomed (DEPO), Spectrum (SPPI), KYTHERA (KYTH), Revance (RVNC), XenoPort (XNPT), Mylan (MYL), Akorn (AKRX), Impax (IPXL), Amphastar Pharmaceuticals (AMPH), Anacor (ANAC) and BioDelivery Sciences (BDSI).
09:23 EDTCLDXCelldex initiates Phase 1/2 study of Varlilumab combination
Subscribe for More Information
07:23 EDTFOXABig four networks aim to own more of their programs, WSJ reports
The percentage of shows that the big four television networks own or have a stake in has risen in recent years as owning shows has become a priority due to lucrative rerun and cross platform rights, said The Wall Street Journal. Walt Disney’s (DIS) ABC will own or have a stake in almost 70% of its coming schedule, compared with 48% in 2010, while Fox (FOXA), CBS (CBS) and Comcast’s (CMCSA) NBC will also own or have stakes in the majority of their lineups' shows, the report noted. Reference Link
May 27, 2015
08:32 EDTCTASCintas management to meet with Pacific Crest
Meeting to be held in Boston on May 28 hosted by Pacific Crest.
May 26, 2015
16:35 EDTECLEcolab, Diversey resolve patent infringement suit through license
Subscribe for More Information
May 25, 2015
12:50 EDTFOXADisney's 'Tomorrowland' leads U.S. weekend box office with $32.2M
Subscribe for More Information
May 19, 2015
08:57 EDTCLDXLeerink biotech analyst holds an analyst/industry conference call
Subscribe for More Information
07:15 EDTECLGoldman Sachs to hold a conference
Subscribe for More Information
07:13 EDTECLBarclays to hold a conference
Subscribe for More Information
May 18, 2015
17:26 EDTFOXAValueAct reports 5.5% stake in 21st Century Fox Class B shares
Subscribe for More Information
10:01 EDTCQPOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: A10 Networks (ATEN) upgraded to Overweight from Sector Weight at Pacific Crest... Cal-Maine Foods (CALM) upgraded to Overweight from Equal Weight at Stephens... ChemoCentryx (CCXI) upgraded to Overweight from Neutral at JPMorgan... Cheniere Energy Partners LP (CQP) upgraded to Buy from Neutral at Goldman... Chicago Bridge & Iron (CBI) upgraded to Neutral from Sell at Goldman... Continental Resources (CLR) upgraded to Buy from Neutral at Goldman... Ctrip.com (CTRP) upgraded to Overweight from Neutral at JPMorgan... Emerge Energy (EMES) upgraded to Buy from Neutral at Goldman... FEMSA (FMX) upgraded to Overweight from Equal Weight at Morgan Stanley... GoPro (GPRO) upgraded to Perform from Underperform at Oppenheimer... Holly Energy (HEP) upgraded to Buy from Neutral at Goldman... JP Energy (JPEP) upgraded on better visibility on volumes at RBC Capital... Laredo Petroleum (LPI) upgraded to Neutral from Sell at Goldman... Malvern Bancorp (MLVF) upgraded to Outperform from Market Perform at Keefe Bruyette... Newfield Exploration (NFX) upgraded to Buy from Neutral at Goldman... Norsk Hydro (NHYDY) upgraded to Overweight from Neutral at JPMorgan... Owens-Illinois (OI) upgraded to Neutral from Underperform at BofA/Merrill... Penn National (PENN) upgraded to Buy from Neutral at Goldman... Roche (RHHBY) upgraded to Buy from Neutral at UBS... Schnitzer Steel (SCHN) upgraded on stabilizing headwinds at KeyBanc... Seventy Seven Energy (SSE) upgraded to Buy from Hold at Jefferies... Toll Brothers (TOL) upgraded to Neutral from Underperform at Sterne Agee CRT... United Therapeutics (UTHR) upgraded to Buy from Neutral at BTIG... Volvo (VOLVY) upgraded to Neutral from Underweight at JPMorgan... Zayo Group (ZAYO) upgraded to Buy from Neutral at Goldman.
07:27 EDTFOXAJPMorgan to hold a conference
Subscribe for More Information
06:53 EDTCQPCheniere Energy Partners LP upgraded to Buy from Neutral at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use